Beyond Acute Kidney Injury : Direct Pathways Implicate Inflammatory Mechanisms in Serum NGAL’s Mortality Effect in Acute Brain Injury
Authors:
- 24 August 2026
- journal article
- research article
- Published by Springer Nature in Translational Stroke Research
- Vol. 17 (5) , 101
Abstract
Neutrophil gelatinase-associated lipocalin (NGAL) is associated with mortality in critically ill patients, conventionally attributed to its role in acute kidney injury (AKI) detection. However, NGAL is a neutrophil granule protein released during innate immune activation—a process central to acute brain injury (ABI) pathophysiology. Whether the association between NGAL and mortality in neurocritical care operates through AKI-mediated or alternative pathways has not been evaluated. In this prospective cohort of 274 adults with ABI (98 intracerebral hemorrhage, 60 ischemic stroke, 46 subarachnoid hemorrhage, 70 traumatic brain injury) admitted to a neurocritical care unit, serum NGAL was measured within 24 h of admission. Causal mediation analysis with time-varying AKI status decomposed NGAL’s mortality effect into direct and AKI-mediated components. High NGAL (≥ 150 ng/mL) was independently associated with in-hospital mortality (adjusted hazard ratio [aHR] 2.94, 95% confidence interval [CI] 1.57–5.51; absolute risk difference 15.0% at 28 days), ICU mortality, 6-month mortality, and worse functional outcomes. Pathway decomposition revealed a significant direct effect not mediated through AKI (aHR 2.15, 95% CI 1.04–4.62, P=.04), whereas the AKI-mediated component was not significant (P=.33). Effects were consistent across injury types. Admission NGAL correlated with subsequent 72-hour systemic inflammatory burden (Spearman ρ = 0.38, P<.001), and within-subject NGAL and interleukin-6 showed concordant temporal trajectories (repeated-measures r = .29, P<.001). These findings indicate that the NGAL–mortality association in ABI includes a significant direct effect not mediated through AKI, implying that NGAL elevation reflects systemic innate immune activation rather than impending renal dysfunction.Keywords
Funding Information
- National Research Foundation of Korea (RS-2025-00517182)
- National Research Foundation of Korea (RS-2025-00556985)
This publication has 44 references indexed in Scilit:
- Epidemiological Patterns and Variability in Acute Brain Injury: A Multicenter Registry Analysis in South Korea’s Neurocritical Care UnitsNeurocritical Care, 2025
- Crosstalk between lipocalin-2 and IL-6 in traumatic brain injury: Closely related biomarkersExperimental Neurology, 2024
- Association of Neurocritical Care Services With Mortality and Functional Outcomes for Adults With Brain InjuryJAMA Neurology, 2022
- Prognosis Predictions by Families, Physicians, and Nurses of Patients with Severe Acute Brain Injury: Agreement and AccuracyNeurocritical Care, 2022
- Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021Intensive Care Medicine, 2021
- Acute ischaemic stroke: challenges for the intensivistIntensive Care Medicine, 2019
- Determination of serum neutrophil gelatinase-associated lipocalin as a prognostic biomarker of acute spontaneous intracerebral hemorrhageClinica Chimica Acta, 2019
- Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trialsThe Lancet, 2016
- Work Group MembershipKidney International Supplements, 2012
- Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU populationIntensive Care Medicine, 2009